Fri, December 8, 2023

Jeffrey Hung Upgraded (BLUE) to Hold and Increased Target to $7 on, Dec 8th, 2023

Jeffrey Hung of Morgan Stanley, Upgraded "bluebird bio, Inc." (BLUE) to Hold and Increased Target from $3 to $7 on, Dec 8th, 2023.

Jeffrey has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Jeffrey's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Eric Schmidt of "Cantor Fitzgerald" Initiated at Hold on, Tuesday, October 17th, 2023


These are the ratings of the 2 analyists that currently disagree with Jeffrey


  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $13 on, Wednesday, November 8th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $4.21 on, Wednesday, September 6th, 2023